Global High Potency API/HPAPI Market - Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Reports
  • May 2019
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global High Potency API/HPAPI Market By Synthesis (Synthetic, Biotech (Biologic, Biosimilar)), Product Type (Innovative, Generic), Manufacturer (Captive, Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Market Analysis: Global High Potency API/HPAPI Market  

Global High Potency API/HPAPI Market   is expected to rise from its initial estimated value of USD 18.7 billion in 2018 to an estimated value of USD 35.4 billion by 2026 registering a CAGR of 8.3%. The upcoming market report contains data for historic year 2017, 2016, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Definition: Global High Potency API/HPAPI Market  

A high potency API /HPAPI use small molecules to supply new patient treatment of respiratory disorders, treatment of cancer and hormonal imbalances. These drugs have minimal side effects and impact targeted areas, thereby helping the patient to recover faster with no lingering after effects.

Market Drivers

  • Growth in the oncology drugs showcase is one of the drivers for the market.
  • Increasing center of pharmaceutical organizations around HPAPIs
  • Rising incidence of cancer is one of the drivers for the market.
  • Developments in HPAPI is growing the awareness for the market.

Market Restraint

  • Stringent administrative necessities will act as restraint for the market.
  • Requirement of extensive ventures is going to slow the growth of the market,

Segmentation: Global High Potency API/HPAPI Market  

By Synthesis

  • Synthetic

    • Innovative Synthetic HPAPI
    • Generic Synthetic HPAPI

  • Biotech
  • Biologic
  • Biosimilar

By Product

  • Innovative
  • Generic

By Manufacturer

  • Captive
  • Merchant

By Application

  • Oncology
  • Glaucoma
  • Hormonal Imbalance

By Geography

  • North America

    • US.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Argentina
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Malaysia
    • Indonesia
    • Thailand
    • Philippines
    • Rest of Asia-Pacific

  • Middle East and Africa

    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In April 2019, Cambrex Corporation provider of drug substance, drug product and analytical services announced that they completed the construction of a $24 million highly potent API (HPAPI) manufacturing facility at Charles City, IA. The new facilities will provide Flexibility to manufacturing network and scale up the projects progress.
  • In October 2018, Lonza a global Leader in Life Sciences announced expansion of its highly potent API (HPAPI) capacity. The two new manufacturing suites for the manufacturing of antibody drug conjugate (ADC) payloads

Competitive Analysis: Global High Potency API/HPAPI Market  

The global high potency API /HPAPI market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. The report includes market shares of high potency API /HPAPI market for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Key Market Competitors: Global High Potency API/HPAPI Market  

Some of the major players of the global high potency API /HPAPI market are WuXiAppTec, Novartis AG, Merck KGaA. F. Hoffmann-La Roche Ltd, Pfizer, Inc., Sandoz International GmbH, Novasep, Medtronic, Lonza,, AbbVie Inc., Sanofi, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd,  Dr. Reddy’s Laboratories Ltd, Cambrex Corporation, Mylan N.V.,   Bayer AG, GlaxoSmithKline plc., Alkermes plc., and others

Research Methodology: Global High Potency Global High Potency API/HPAPI Market  

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry. The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global high potency API /HPAPI market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART